Medical Care

Global Bacteriophage Therapy Market Research Report 2025

The global market for Bacteriophage Therapy was valued at US$ 38.6 million in the year 2024 and is projected to reach a revised size of US$ 72.7 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy.
The Bacteriophage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Segment by Type
Oral
Topical
Parenteral
Segment by Application
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Topical
1.2.4 Parenteral
1.3 Market by Application
1.3.1 Global Bacteriophage Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Organ Transplantation
1.3.3 Bacterial Infections
1.3.4 Alcoholic Hepatitis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Therapy Market Perspective (2020-2031)
2.2 Global Bacteriophage Therapy Growth Trends by Region
2.2.1 Global Bacteriophage Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bacteriophage Therapy Historic Market Size by Region (2020-2025)
2.2.3 Bacteriophage Therapy Forecasted Market Size by Region (2026-2031)
2.3 Bacteriophage Therapy Market Dynamics
2.3.1 Bacteriophage Therapy Industry Trends
2.3.2 Bacteriophage Therapy Market Drivers
2.3.3 Bacteriophage Therapy Market Challenges
2.3.4 Bacteriophage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Therapy Players by Revenue
3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2020-2025)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bacteriophage Therapy Revenue
3.4 Global Bacteriophage Therapy Market Concentration Ratio
3.4.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2024
3.5 Global Key Players of Bacteriophage Therapy Head office and Area Served
3.6 Global Key Players of Bacteriophage Therapy, Product and Application
3.7 Global Key Players of Bacteriophage Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Therapy Breakdown Data by Type
4.1 Global Bacteriophage Therapy Historic Market Size by Type (2020-2025)
4.2 Global Bacteriophage Therapy Forecasted Market Size by Type (2026-2031)
5 Bacteriophage Therapy Breakdown Data by Application
5.1 Global Bacteriophage Therapy Historic Market Size by Application (2020-2025)
5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bacteriophage Therapy Market Size (2020-2031)
6.2 North America Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bacteriophage Therapy Market Size by Country (2020-2025)
6.4 North America Bacteriophage Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bacteriophage Therapy Market Size (2020-2031)
7.2 Europe Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bacteriophage Therapy Market Size by Country (2020-2025)
7.4 Europe Bacteriophage Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Therapy Market Size (2020-2031)
8.2 Asia-Pacific Bacteriophage Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bacteriophage Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Bacteriophage Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bacteriophage Therapy Market Size (2020-2031)
9.2 Latin America Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bacteriophage Therapy Market Size by Country (2020-2025)
9.4 Latin America Bacteriophage Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Therapy Market Size (2020-2031)
10.2 Middle East & Africa Bacteriophage Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bacteriophage Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Bacteriophage Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Details
11.1.2 Armata Pharmaceuticals, Inc. Business Overview
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction
11.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.1.5 Armata Pharmaceuticals, Inc. Recent Development
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Details
11.2.2 Eliava Biopreparations Ltd. Business Overview
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction
11.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)
11.2.5 Eliava Biopreparations Ltd. Recent Development
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Details
11.3.2 Pherecydes Pharma Business Overview
11.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction
11.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2020-2025)
11.3.5 Pherecydes Pharma Recent Development
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Details
11.4.2 Intralytix, Inc. Business Overview
11.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction
11.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.4.5 Intralytix, Inc. Recent Development
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Details
11.5.2 Phagelux Inc. Business Overview
11.5.3 Phagelux Inc. Bacteriophage Therapy Introduction
11.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.5.5 Phagelux Inc. Recent Development
11.6 Nextbiotics
11.6.1 Nextbiotics Company Details
11.6.2 Nextbiotics Business Overview
11.6.3 Nextbiotics Bacteriophage Therapy Introduction
11.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2020-2025)
11.6.5 Nextbiotics Recent Development
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Details
11.7.2 InnoPhage, Ltd Business Overview
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction
11.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2020-2025)
11.7.5 InnoPhage, Ltd Recent Development
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Details
11.8.2 Locus Biosciences, Inc. Business Overview
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction
11.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.8.5 Locus Biosciences, Inc. Recent Development
11.9 TechnoPhage
11.9.1 TechnoPhage Company Details
11.9.2 TechnoPhage Business Overview
11.9.3 TechnoPhage Bacteriophage Therapy Introduction
11.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2020-2025)
11.9.5 TechnoPhage Recent Development
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Details
11.10.2 Eligo Bioscience SA Business Overview
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction
11.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2020-2025)
11.10.5 Eligo Bioscience SA Recent Development
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Details
11.11.2 Phagomed Biopharma GmbH. Business Overview
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction
11.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2020-2025)
11.11.5 Phagomed Biopharma GmbH. Recent Development
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Details
11.12.2 PhagePro, Inc. Business Overview
11.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction
11.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.12.5 PhagePro, Inc. Recent Development
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Details
11.13.2 Adaptive Phage Therapeutics, Inc. Business Overview
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction
11.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.13.5 Adaptive Phage Therapeutics, Inc. Recent Development
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Details
11.14.2 EnBiotix, Inc. Business Overview
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction
11.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.14.5 EnBiotix, Inc. Recent Development
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Details
11.15.2 Intodeworld, Inc. Business Overview
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction
11.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2020-2025)
11.15.5 Intodeworld, Inc. Recent Development
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Details
11.16.2 BiomX Ltd. Business Overview
11.16.3 BiomX Ltd. Bacteriophage Therapy Introduction
11.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)
11.16.5 BiomX Ltd. Recent Development
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Details
11.17.2 Phi Therapeutics Business Overview
11.17.3 Phi Therapeutics Bacteriophage Therapy Introduction
11.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2020-2025)
11.17.5 Phi Therapeutics Recent Development
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Details
11.18.2 Fixed-phage Ltd. Business Overview
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction
11.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2020-2025)
11.18.5 Fixed-phage Ltd. Recent Development
11.19 Micreos BV
11.19.1 Micreos BV Company Details
11.19.2 Micreos BV Business Overview
11.19.3 Micreos BV Bacteriophage Therapy Introduction
11.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2020-2025)
11.19.5 Micreos BV Recent Development
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Details
11.20.2 ContraFect Corporation Business Overview
11.20.3 ContraFect Corporation Bacteriophage Therapy Introduction
11.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2020-2025)
11.20.5 ContraFect Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Bacteriophage Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Topical
Table 4. Key Players of Parenteral
Table 5. Global Bacteriophage Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Bacteriophage Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Bacteriophage Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Bacteriophage Therapy Market Share by Region (2020-2025)
Table 9. Global Bacteriophage Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Bacteriophage Therapy Market Share by Region (2026-2031)
Table 11. Bacteriophage Therapy Market Trends
Table 12. Bacteriophage Therapy Market Drivers
Table 13. Bacteriophage Therapy Market Challenges
Table 14. Bacteriophage Therapy Market Restraints
Table 15. Global Bacteriophage Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Bacteriophage Therapy Market Share by Players (2020-2025)
Table 17. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2024)
Table 18. Ranking of Global Top Bacteriophage Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Bacteriophage Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Bacteriophage Therapy, Headquarters and Area Served
Table 21. Global Key Players of Bacteriophage Therapy, Product and Application
Table 22. Global Key Players of Bacteriophage Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bacteriophage Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Bacteriophage Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Bacteriophage Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Bacteriophage Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Bacteriophage Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Bacteriophage Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Bacteriophage Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Bacteriophage Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Bacteriophage Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Bacteriophage Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Bacteriophage Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Bacteriophage Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Bacteriophage Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Bacteriophage Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Armata Pharmaceuticals, Inc. Company Details
Table 48. Armata Pharmaceuticals, Inc. Business Overview
Table 49. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product
Table 50. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 51. Armata Pharmaceuticals, Inc. Recent Development
Table 52. Eliava Biopreparations Ltd. Company Details
Table 53. Eliava Biopreparations Ltd. Business Overview
Table 54. Eliava Biopreparations Ltd. Bacteriophage Therapy Product
Table 55. Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 56. Eliava Biopreparations Ltd. Recent Development
Table 57. Pherecydes Pharma Company Details
Table 58. Pherecydes Pharma Business Overview
Table 59. Pherecydes Pharma Bacteriophage Therapy Product
Table 60. Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 61. Pherecydes Pharma Recent Development
Table 62. Intralytix, Inc. Company Details
Table 63. Intralytix, Inc. Business Overview
Table 64. Intralytix, Inc. Bacteriophage Therapy Product
Table 65. Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 66. Intralytix, Inc. Recent Development
Table 67. Phagelux Inc. Company Details
Table 68. Phagelux Inc. Business Overview
Table 69. Phagelux Inc. Bacteriophage Therapy Product
Table 70. Phagelux Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 71. Phagelux Inc. Recent Development
Table 72. Nextbiotics Company Details
Table 73. Nextbiotics Business Overview
Table 74. Nextbiotics Bacteriophage Therapy Product
Table 75. Nextbiotics Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 76. Nextbiotics Recent Development
Table 77. InnoPhage, Ltd Company Details
Table 78. InnoPhage, Ltd Business Overview
Table 79. InnoPhage, Ltd Bacteriophage Therapy Product
Table 80. InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 81. InnoPhage, Ltd Recent Development
Table 82. Locus Biosciences, Inc. Company Details
Table 83. Locus Biosciences, Inc. Business Overview
Table 84. Locus Biosciences, Inc. Bacteriophage Therapy Product
Table 85. Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 86. Locus Biosciences, Inc. Recent Development
Table 87. TechnoPhage Company Details
Table 88. TechnoPhage Business Overview
Table 89. TechnoPhage Bacteriophage Therapy Product
Table 90. TechnoPhage Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 91. TechnoPhage Recent Development
Table 92. Eligo Bioscience SA Company Details
Table 93. Eligo Bioscience SA Business Overview
Table 94. Eligo Bioscience SA Bacteriophage Therapy Product
Table 95. Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 96. Eligo Bioscience SA Recent Development
Table 97. Phagomed Biopharma GmbH. Company Details
Table 98. Phagomed Biopharma GmbH. Business Overview
Table 99. Phagomed Biopharma GmbH. Bacteriophage Therapy Product
Table 100. Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 101. Phagomed Biopharma GmbH. Recent Development
Table 102. PhagePro, Inc. Company Details
Table 103. PhagePro, Inc. Business Overview
Table 104. PhagePro, Inc. Bacteriophage Therapy Product
Table 105. PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 106. PhagePro, Inc. Recent Development
Table 107. Adaptive Phage Therapeutics, Inc. Company Details
Table 108. Adaptive Phage Therapeutics, Inc. Business Overview
Table 109. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product
Table 110. Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 111. Adaptive Phage Therapeutics, Inc. Recent Development
Table 112. EnBiotix, Inc. Company Details
Table 113. EnBiotix, Inc. Business Overview
Table 114. EnBiotix, Inc. Bacteriophage Therapy Product
Table 115. EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 116. EnBiotix, Inc. Recent Development
Table 117. Intodeworld, Inc. Company Details
Table 118. Intodeworld, Inc. Business Overview
Table 119. Intodeworld, Inc. Bacteriophage Therapy Product
Table 120. Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 121. Intodeworld, Inc. Recent Development
Table 122. BiomX Ltd. Company Details
Table 123. BiomX Ltd. Business Overview
Table 124. BiomX Ltd. Bacteriophage Therapy Product
Table 125. BiomX Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 126. BiomX Ltd. Recent Development
Table 127. Phi Therapeutics Company Details
Table 128. Phi Therapeutics Business Overview
Table 129. Phi Therapeutics Bacteriophage Therapy Product
Table 130. Phi Therapeutics Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 131. Phi Therapeutics Recent Development
Table 132. Fixed-phage Ltd. Company Details
Table 133. Fixed-phage Ltd. Business Overview
Table 134. Fixed-phage Ltd. Bacteriophage Therapy Product
Table 135. Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 136. Fixed-phage Ltd. Recent Development
Table 137. Micreos BV Company Details
Table 138. Micreos BV Business Overview
Table 139. Micreos BV Bacteriophage Therapy Product
Table 140. Micreos BV Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 141. Micreos BV Recent Development
Table 142. ContraFect Corporation Company Details
Table 143. ContraFect Corporation Business Overview
Table 144. ContraFect Corporation Bacteriophage Therapy Product
Table 145. ContraFect Corporation Revenue in Bacteriophage Therapy Business (2020-2025) & (US$ Million)
Table 146. ContraFect Corporation Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Bacteriophage Therapy Picture
Figure 2. Global Bacteriophage Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bacteriophage Therapy Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Topical Features
Figure 6. Parenteral Features
Figure 7. Global Bacteriophage Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Bacteriophage Therapy Market Share by Application: 2024 VS 2031
Figure 9. Organ Transplantation Case Studies
Figure 10. Bacterial Infections Case Studies
Figure 11. Alcoholic Hepatitis Case Studies
Figure 12. Other Case Studies
Figure 13. Bacteriophage Therapy Report Years Considered
Figure 14. Global Bacteriophage Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Bacteriophage Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Bacteriophage Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Bacteriophage Therapy Market Share by Players in 2024
Figure 18. Global Top Bacteriophage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteriophage Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Bacteriophage Therapy Revenue in 2024
Figure 20. North America Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Bacteriophage Therapy Market Share by Country (2020-2031)
Figure 22. United States Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Bacteriophage Therapy Market Share by Country (2020-2031)
Figure 26. Germany Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Bacteriophage Therapy Market Share by Region (2020-2031)
Figure 34. China Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Bacteriophage Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Bacteriophage Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Bacteriophage Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 50. Eliava Biopreparations Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 51. Pherecydes Pharma Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 52. Intralytix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 53. Phagelux Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 54. Nextbiotics Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 55. InnoPhage, Ltd Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 56. Locus Biosciences, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 57. TechnoPhage Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 58. Eligo Bioscience SA Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 59. Phagomed Biopharma GmbH. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 60. PhagePro, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 61. Adaptive Phage Therapeutics, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 62. EnBiotix, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 63. Intodeworld, Inc. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 64. BiomX Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 65. Phi Therapeutics Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 66. Fixed-phage Ltd. Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 67. Micreos BV Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 68. ContraFect Corporation Revenue Growth Rate in Bacteriophage Therapy Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies